These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6482645)

  • 1. The effect of desmethylimipramine on the metabolism of norepinephrine.
    Zavadil AP; Ross RJ; Calil HM; Linnoila M; Blombery P; Jimerson DC; Kopin IJ; Potter WZ
    Life Sci; 1984 Sep; 35(10):1061-8. PubMed ID: 6482645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma 3,4-dihydroxyphenylglycol (DHPG) and 3-methoxy-4-hydroxyphenylglycol (MHPG) are insensitive indicators of alpha 2-adrenoceptor mediated regulation of norepinephrine release in healthy human volunteers.
    Scheinin M; Karhuvaara S; Ojala-Karlsson P; Kallio A; Koulu M
    Life Sci; 1991; 49(1):75-84. PubMed ID: 1646924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Source and physiological significance of plasma 3,4-dihydroxyphenylglycol and 3-methoxy-4-hydroxyphenylglycol.
    Eisenhofer G; Goldstein DS; Ropchak TG; Nguyen HQ; Keiser HR; Kopin IJ
    J Auton Nerv Syst; 1988 Sep; 24(1-2):1-14. PubMed ID: 3209794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norepinephrine metabolism in neuron: dissociation between 3,4-dihydroxyphenylglycol and 3,4-dihydroxymandelic acid pathways.
    Dong WX; Ni XL
    Acta Pharmacol Sin; 2002 Jan; 23(1):59-65. PubMed ID: 11860739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuronal and extraneuronal origins of plasma 3-methoxy-4-hydroxyphenylglycol in rats.
    Eisenhofer G; Pecorella W; Pacak K; Hooper D; Kopin IJ; Goldstein DS
    J Auton Nerv Syst; 1994 Dec; 50(1):93-107. PubMed ID: 7844319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative importance of 3-methoxy-4-hydroxyphenylglycol and 3,4-dihydroxyphenylglycol as norepinephrine metabolites in rat, monkey, and humans.
    Elsworth JD; Roth RH; Redmond DE
    J Neurochem; 1983 Sep; 41(3):786-93. PubMed ID: 6875564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further characterization of brain 3,4-dihydroxyphenylethyleneglycol (DHPG) formation: dependence on noradrenergic activity and site of formation.
    Li PP; Warsh JJ; Godse DD
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):26-33. PubMed ID: 3951564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments.
    Karoum F; Korpi ER; Linnoila M; Chuang LW; Wyatt RJ
    Eur J Pharmacol; 1984 Apr; 100(2):137-44. PubMed ID: 6234178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans.
    Goldstein DS; Eisenhofer G; Stull R; Folio CJ; Keiser HR; Kopin IJ
    J Clin Invest; 1988 Jan; 81(1):213-20. PubMed ID: 3335637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo monitoring of norepinephrine and its metabolites in skeletal muscle.
    Tokunaga N; Yamazaki T; Akiyama T; Sano S; Mori H
    Neurochem Int; 2003 Nov; 43(6):573-80. PubMed ID: 12820986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the utility of urinary 3,4-dihydroxyphenylethylene-glycol (DHPG) measurement.
    Li PP; Warsh JJ; Godse DD; Guttman M
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):717-20. PubMed ID: 4089197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Method for simultaneous measurement of norepinephrine, 3-methoxy-4-hydroxyphenylglycol and 3,4-dihydroxyphenylglycol by liquid chromatography with electrochemical detection: application in rat cerebral cortex and plasma after lithium chloride treatment.
    Sastre E; Nicolay A; Bruguerolle B; Portugal H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Mar; 801(2):205-11. PubMed ID: 14751788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma MHPG in depression: effects of acute and chronic desipramine treatment.
    Charney DS; Heninger GR; Sternberg DE; Roth RH
    Psychiatry Res; 1981 Oct; 5(2):217-29. PubMed ID: 6945615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialysate dihydroxyphenylglycol as a window for in situ axoplasmic norepinephrine disposition.
    Yamazaki T; Akiyama T; Kitagwa H; Kawada T; Sunagawa K
    Neurochem Int; 2001 Mar; 38(3):287-92. PubMed ID: 11099788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of desmethylimipramine on plasma norepinephrine, pulse, and blood pressure.
    Ross RJ; Zavadil AP; Calil HM; Linnoila M; Kitanaka I; Blombery P; Kopin IJ; Potter WZ
    Clin Pharmacol Ther; 1983 Apr; 33(4):429-37. PubMed ID: 6831821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of childhood hyperactivity with desipramine: plasma drug concentration, cardiovascular effects, plasma and urinary catecholamine levels, and clinical response.
    Donnelly M; Zametkin AJ; Rapoport JL; Ismond DR; Weingartner H; Lane E; Oliver J; Linnoila M; Potter WZ
    Clin Pharmacol Ther; 1986 Jan; 39(1):72-81. PubMed ID: 3510796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on 3-methoxy-4-hydroxyphenylglycol (MHPG) and 3,4-dihydroxyphenylglycol (DHPG) levels in human urine, plasma and cerebrospinal fluids, and their significance in studies of depression.
    Tsuji M; Yamane H; Yamada N; Iida H; Taga C; Myojin T
    Jpn J Psychiatry Neurol; 1986 Mar; 40(1):47-56. PubMed ID: 3773351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and chronic effects of desipramine administration to rhesus monkeys.
    Insel TR; Lane EA; Sheinin M; Linnoila M
    Eur J Pharmacol; 1987 Apr; 136(1):63-8. PubMed ID: 3595717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydroxyphenylglycol and intraneuronal metabolism of endogenous and exogenous norepinephrine in the rat vas deferens.
    Eisenhofer G; Ropchak TG; Stull RW; Goldstein DS; Keiser HR; Kopin IJ
    J Pharmacol Exp Ther; 1987 May; 241(2):547-53. PubMed ID: 3572811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating dihydroxyphenylglycol and norepinephrine concentrations during sympathetic nervous system activation in patients with pheochromocytoma.
    Atuk NO; Hanks JB; Weltman J; Bogdonoff DL; Boyd DG; Vance ML
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1609-14. PubMed ID: 7989464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.